Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Dun, Liang"'
Publikováno v:
Graphical Models, Vol 130, Iss , Pp 101202- (2023)
Differentiable rendering has been proven as a powerful tool to bridge 2D images and 3D models. With the aid of differentiable rendering, tasks in computer vision and computer graphics could be solved more elegantly and accurately. To address challeng
Externí odkaz:
https://doaj.org/article/94725191eb9145098c68e3c228c90250
Publikováno v:
Computational Visual Media, Vol 7, Iss 3, Pp 283-288 (2021)
Externí odkaz:
https://doaj.org/article/afbaa95097f945ff847cf3fbdf8a4b51
Autor:
Harpreet Singh, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Paul G. Kluetz, Shenghui Tang, Autumn Zack-Taylor, Reena Philip, Donna Roscoe, Soma Ghosh, Dun Liang, Francisca Reyes Turcu, Rosane Charlab, Jiang Liu, Yangbing Li, Jeanne Fourie Zirkelbach, Lauren S.L. Price, Whitney S. Helms, Amy M. Skinner, Lisa Rodriguez, Sirisha L. Mushti, Erin Larkins, Diana Bradford
On May 8, 2020, the FDA granted accelerated approval to selpercatinib for (i) adult patients with metastatic RET fusion–positive non–small cell lung cancer (NSCLC), (ii) adult and pediatric patients ≥12 years of age with advanced or metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be7343eb8f94d802c06ee615ed48b00e
https://doi.org/10.1158/1078-0432.c.6531198.v1
https://doi.org/10.1158/1078-0432.c.6531198.v1
Autor:
Harpreet Singh, Julia A. Beaver, Marc R. Theoret, Richard Pazdur, Reena Philip, Soma Ghosh, Dun Liang, Hong Zhao, Jiang Liu, Rosane Charlab, Jielin Sun, Youwei Bi, Amal Ayyoub, Whitney S. Helms, Emily Wearne, Pallavi S. Mishra-Kalyani, Somak Chatterjee, Lee H. Pai-Scherf, Erin Larkins, Diana Bradford, Janice Kim
Supplementary Tables S1-S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4b5d26de3d7ddf0a7029f07d3d7773
https://doi.org/10.1158/1078-0432.22481316.v1
https://doi.org/10.1158/1078-0432.22481316.v1
Autor:
Harpreet Singh, Marc R. Theoret, Richard Pazdur, Julia A. Beaver, Paul G. Kluetz, Shenghui Tang, Autumn Zack-Taylor, Reena Philip, Donna Roscoe, Soma Ghosh, Dun Liang, Francisca Reyes Turcu, Rosane Charlab, Jiang Liu, Yangbing Li, Jeanne Fourie Zirkelbach, Lauren S.L. Price, Whitney S. Helms, Amy M. Skinner, Lisa Rodriguez, Sirisha L. Mushti, Erin Larkins, Diana Bradford
Supplementary Tables 1 - 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1bec6ad892cdfcb192e429eefae90a
https://doi.org/10.1158/1078-0432.22483665.v1
https://doi.org/10.1158/1078-0432.22483665.v1
Autor:
Michael G. Becker, Dun Liang, Breanna Cooper, Yan Le, Tracy Taylor, Emma R. Lee, Sutan Wu, Paul Sandstrom, Hezhao Ji
Publikováno v:
Viruses, Vol 12, Iss 6, p 627 (2020)
Next-generation sequencing (NGS)-based HIV drug resistance (HIVDR) assays outperform conventional Sanger sequencing in scalability, sensitivity, and quantitative detection of minority resistance variants. Thus far, HIVDR assays have been applied prim
Externí odkaz:
https://doaj.org/article/5a45446240144d1caf863bc7fb173792
Autor:
Dun Liang1 liangdun@hynu.edu.cn
Publikováno v:
New York Journal of Mathematics. 2020, p636-655. 20p.
Publikováno v:
Computational Visual Media, Vol 7, Iss 3, Pp 283-288 (2021)
In the first week of May, 2021, researchers from four different institutions: Google, Tsinghua University, Oxford University and Facebook, shared their latest work [16, 7, 12, 17] on arXiv.org almost at the same time, each proposing new learning arch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ee883016bc4c77f79852a76ed7b49c
https://doi.org/10.1007/s41095-021-0240-x
https://doi.org/10.1007/s41095-021-0240-x
Autor:
Janice Kim, Diana Bradford, Erin Larkins, Lee H. Pai-Scherf, Somak Chatterjee, Pallavi S. Mishra-Kalyani, Emily Wearne, Whitney S. Helms, Amal Ayyoub, Youwei Bi, Jielin Sun, Rosane Charlab, Jiang Liu, Hong Zhao, Dun Liang, Soma Ghosh, Reena Philip, Richard Pazdur, Marc R. Theoret, Julia A. Beaver, Harpreet Singh
Publikováno v:
Clinical Cancer Research. 27:5452-5456
The FDA granted accelerated approval for pralsetinib on September 4, 2020 for non–small cell lung cancer (NSCLC) and December 1, 2020 for thyroid cancer, for: (i) adult patients with metastatic RET fusion–positive NSCLC, (ii) adult and pediatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffa3f02843d33f5662a70e29c68838da
https://doi.org/10.1158/1078-0432.ccr-21-0967
https://doi.org/10.1158/1078-0432.ccr-21-0967
Publikováno v:
Thin-Walled Structures. 186:110713
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8175118ff8b7807c0fe1ab462c25ba9
https://doi.org/10.1016/j.tws.2023.110713
https://doi.org/10.1016/j.tws.2023.110713